- Report
- November 2023
- 175 Pages
Global
From €4803EUR$5,000USD£4,124GBP
- Report
- December 2023
- 283 Pages
Global
From €5236EUR$5,450USD£4,495GBP
- Report
- January 2023
- 206 Pages
Global
From €3043EUR$3,168USD£2,613GBP
€3458EUR$3,600USD£2,969GBP
- Report
- January 2023
- 97 Pages
Global
From €3358EUR$3,495USD£2,883GBP
- Report
- October 2023
- 174 Pages
Global
From €4707EUR$4,900USD£4,042GBP
- Report
- October 2023
- 186 Pages
Global
From €3414EUR$3,554USD£2,932GBP
€3794EUR$3,949USD£3,257GBP
- Report
- September 2023
- 175 Pages
Global
From €3843EUR$4,000USD£3,299GBP
€4803EUR$5,000USD£4,124GBP
- Report
- June 2023
- 275 Pages
Global
From €3843EUR$4,000USD£3,299GBP
€4803EUR$5,000USD£4,124GBP
- Report
- December 2023
- 288 Pages
Global
From €5380EUR$5,600USD£4,619GBP
- Report
- December 2023
- 271 Pages
Global
From €5236EUR$5,450USD£4,495GBP
- Report
- November 2023
- 143 Pages
Global
From €2401EUR$2,499USD£2,061GBP
- Report
- September 2023
- 149 Pages
Global
From €2161EUR$2,249USD£1,855GBP
€2401EUR$2,499USD£2,061GBP
- Report
- November 2023
- 245 Pages
Global
€4799EUR$4,995USD£4,120GBP
- Report
- October 2023
- 183 Pages
Global
From €3414EUR$3,554USD£2,932GBP
€3794EUR$3,949USD£3,257GBP
- Report
- October 2023
- 180 Pages
Global
From €4707EUR$4,900USD£4,042GBP
- Report
- November 2023
- 30 Pages
Global
From €2114EUR$2,200USD£1,815GBP
€2642EUR$2,750USD£2,268GBP
- Report
- November 2023
- 30 Pages
Global
From €2498EUR$2,600USD£2,145GBP
€3122EUR$3,250USD£2,681GBP
- Clinical Trials
- July 2023
- 80 Pages
Global
From €1537EUR$1,600USD£1,320GBP
€1921EUR$2,000USD£1,650GBP
- Report
- February 2023
- 268 Pages
Global
From €5505EUR$5,730USD£4,726GBP
- Report
- July 2023
- 140 Pages
Global
From €3879EUR$4,038USD£3,330GBP
€4563EUR$4,750USD£3,918GBP

The Bladder Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat bladder cancer. Bladder cancer is a type of cancer that affects the urinary tract and is the sixth most common type of cancer in the United States. Common treatments for bladder cancer include chemotherapy, radiation therapy, and surgery.
Drugs used to treat bladder cancer are typically classified as either targeted therapies or immunotherapies. Targeted therapies are designed to target specific molecules or pathways in the body that are involved in the growth and spread of cancer cells. Immunotherapies are designed to stimulate the body’s own immune system to fight cancer cells.
Some of the major companies in the Bladder Cancer Drugs market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are involved in the development and sale of drugs used to treat bladder cancer. Show Less Read more